e-learning
resources
Barcelona 2010
Sunday, 19.09.2010
Mechanisms of late allograft dysfunction: new insights
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Protein profiling in two different phenotypes of bronchiolitis obliterans syndrome after lung transplantation
S. E. Verleden, R. Vos, S. I. De Vleesschauwer, S. Willems, V. Mertens, A. Willems-Widyastuti, L. J. Dupont, B. M. Vanaudenaerde, G. M. Verleden, D. E. Van Raemdonck (Leuven, Belgium)
Source:
Annual Congress 2010 - Mechanisms of late allograft dysfunction: new insights
Session:
Mechanisms of late allograft dysfunction: new insights
Session type:
Oral Presentation
Number:
1684
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
S. E. Verleden, R. Vos, S. I. De Vleesschauwer, S. Willems, V. Mertens, A. Willems-Widyastuti, L. J. Dupont, B. M. Vanaudenaerde, G. M. Verleden, D. E. Van Raemdonck (Leuven, Belgium). Protein profiling in two different phenotypes of bronchiolitis obliterans syndrome after lung transplantation. Eur Respir J 2010; 36: Suppl. 54, 1684
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
The impact of anti-IgE treatment on the airway microbiome in asthma.
Special issues in elderly people with solitary pulmonary nodule: non intubated thoracic surgery
Lung transplantation
Related content which might interest you:
Prevalence and outcome of bronchiolitis obliterans syndrome after lung transplantation
Source: Eur Respir J 2004; 24: Suppl. 48, 177s
Year: 2004
Multiple breath washout in bronchiolitis obliterans syndrome following paediatric lung transplantation
Source: Annual Congress 2012 - Lung transplantation: studies in candidates and recipients
Year: 2012
Bronchiolitis obliterans syndrome and bronchiolitis obliterans in lung transplantation: will a pathologist and a physician ever meet?
Source: ISSN=1025-448x, ISBN=1-904097-33-2, page=55
Year: 2004
A dichotomy in bronchiolitis obliterans syndrome after lung transplantation revealed by azithromycin therapy
Source: Eur Respir J 2008; 32: 832-842
Year: 2008
Montelukast as a rescue therapy for bronchiolitis obliterans syndrome (BOS) after lung transplantation
Source: Annual Congress 2011 - Improving outcomes after lung transplantation
Year: 2011
Is it bronchiolitis obliterans syndrome or is it chronic rejection: a reappraisal?
Source: Eur Respir J 2005; 25: 221-224
Year: 2005
Static lung volumes in lung transplant recipients with bronchiolitis obliterans syndrome
Source: Annual Congress 2011 - Lung function today and tomorrow II
Year: 2011
Bronchiolitis obliterans syndrome after lung transplantation: diagnosis and treatment
Source: ISSN=1025-448x, ISBN=1-904097-33-2, page=19
Year: 2004
Serum KL-6 as a marker for bronchiolitis obliterans syndrome after lung transplantation
Source: Annual Congress 2008 - Donor organs and complications after lung transplantation
Year: 2008
Bronchiolitis obliterans syndrome after single lung transplantation: impact of time to onset on functional pattern and survival
Source: Eur Respir J 2002; 20: Suppl. 38, 563s
Year: 2002
Bronchiectasis as prognostic factor in bronchiolitis obliterans syndrome after lung transplantation
Source: International Congress 2018 – Lung transplant science: from primary graft to chronic allograft dysfunction
Year: 2018
Infection and bronchiolitis obliterans syndrome in lung transplant recipients
Source: ISSN=1025-448x, ISBN=1-904097-33-2, page=44
Year: 2004
The effect of baseline lung function on the determination of time to bronchiolitis obliterans syndrome
Source: Annual Congress 2007 - New insights into clinical lung transplantation
Year: 2007
The effect of baseline lung function on the determination of time to bronchiolitis obliterans syndrome
Source: Eur Respir Rev 2008; 17: 90-92
Year: 2008
Total lymphoid irradiation in progressive bronchiolitis obliterans syndrome after lung transplantation
Source: International Congress 2014 – Post-transplant complications: from pathogenesis to treatment
Year: 2014
Antimicrobial peptides in lung transplant recipients with bronchiolitis obliterans syndrome
Source: Eur Respir J 2008; 32: 670-677
Year: 2008
Towards a model of bronchiolitis obliterans syndrome in single lung transplanted mice
Source: Annual Congress 2010 - Mechanisms of late allograft dysfunction: new insights
Year: 2010
Incidence and risk factors for bronchiolitis obliterans syndrome stage 0p after lung transplantation
Source: International Congress 2018 – Moving lung transplantation forward
Year: 2018
Calcineurin inhibitors in bronchiolitis obliterans syndrome following stem cell transplantation
Source: Eur Respir J 2014; 43: 221-232
Year: 2004
Lung clearance index in detection of post-transplant bronchiolitis obliterans syndrome
Source: ERJ Open Res, 5 (4) 00164-2019; 10.1183/23120541.00164-2019
Year: 2019
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept